VBIO Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Stats
Dzisiejszy wolumen	64 215.00
Średni wolumen	98 131.00
Kapitalizacja rynkowa	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.60
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-29	Loconti Joseph E.	Buy	1 000	Common Stock, par value $0.001 per share
2021-07-20	Loconti Joseph E.	Buy	13 000	Common Stock, par value $0.001 per share
2021-07-19	Loconti Joseph E.	Buy	20 000	Common Stock, par value $0.001 per share
2021-07-19	Loconti Joseph E.	Buy	67 000	Common Stock, par value $0.001 per share
2021-07-19	Loconti Joseph E.	Buy	40 000	Common Stock, par value $0.001 per share

INSIDER POWER
0.00
Last 43 transactions
Buy: 13 752 971 \| Sell: 3 655 234

Vitality Biopharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vitality Biopharma, Inc. Finanse

Annual	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0200

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0200

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (100.00 %)
EPS:	$-0.0847

FY	2019
Przychody:	$0.00
Zysk brutto:	$0.00 (-42.53 %)
EPS:	$-0.610

Financial Reports:

No articles found.

Vitality Biopharma, Inc.

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.